Pürblack, a science-driven wellness company recognized for providing the highest-quality shilajit and advanced peptide formulations, is calling on the wellness industry to raise the bar on ...
OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or the “Company”), the world leader in listeria-based cancer ...
Phase 1b study to evaluate combination of zongertinib and zanidatamab in HER2-positive breast cancer patients Ingelheim, Germany? 12 January, 2026 ? Boehringer Ingelheim today announced a strategic ...
Eisai And Nuvation Bio Enter Into Exclusive Licensing Agreement For Taletrectinib In Europe And Additional Countries Outside The U.S., China And Japan. Eisai and Nuvation Bio Enter into Exclusive ...
Announces receipt of FDA letter stating it has identified deficiencies that preclude labeling discussions for Anaphylm at this time Receives ...
Announces receipt of FDA letter stating it has identified deficiencies that preclude labeling discussions for Anaphylm at this time Receives confirmation from FDA that Agency's review of Anaphylm NDA ...
MINNEAPOLIS, MN, UNITED STATES, January 11, 2026 /EINPresswire.com/ -- Itiliti Health is proud to announce that South ...
AI clinical conversation platform Abridge is partnering with health information network Availity to launch a real-time prior ...
Abridge is partnering with real-time health information network Availity to fire up AI-powered prior authorization, expanding ...
As Secretary of State, the President’s onetime foe now offers him lavish displays of public praise—and will execute his ...
This news release constitutes a “designated news release” for the purposes of the Company’s amended and restated ...
Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) ("Auxly" or the "Company") a leading consumer packaged goods company in the cannabis products market, provides a review of milestones in 2025 and an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback